China Risun GP (01907): Hebei Xuyang Energy received a capital injection of 495 million yuan from Guozhi Qixu Fund.
China Xuyang Group (01907) announced that on June 26, 2026, the company, Xuyang Group, Xiamen Xiangyue, Hebei Xuyang Energy and Guozhiqi Xufund entered into an investment agreement. Guozhiqi Xufund agreed to inject RMB 495,000,000 into Hebei Xuyang Energy in cash, of which RMB 106,915,369.71 will be included in the registered capital of Hebei Xuyang Energy, and the surplus amount of RMB 388,084,630.29 will be included in its capital reserve.
CHINA RISUN GP (01907) announced that on June 26, 2026, the company, Xuyang Group, Xiamen Xiangyue, Hebei Xuyang Energy, and Guozhi Qixu Fund entered into an investment agreement. Guozhi Qixu Fund agreed to inject RMB 495,000,000 in cash into Hebei Xuyang Energy, with RMB 106,915,369.71 to be included in Hebei Xuyang Energy's registered capital, and the excess amount of RMB 388,084,630.29 to be included in its capital surplus.
Before this capital increase, Xuyang Group and Xiamen Xiangyue held 93.8403% and 6.1597% equity in Hebei Xuyang Energy, respectively. After the capital increase, Hebei Xuyang Energy's registered capital will increase from RMB 1,295,943,875.33 to RMB 1,402,859,245.04, with Xuyang Group, Xiamen Xiangyue, and Guozhi Qixu Fund holding 86.6885%, 5.6903%, and 7.6212% equity, respectively. Hebei Xuyang Energy will remain a subsidiary of the company after the capital increase, and its accounts will continue to be consolidated in the group's financial statements.
The directors believe that this capital increase, utilizing the respective capital strengths of both parties, will expand and strengthen the strategic cooperation between Jiu Longjiang Group and the company, thus benefiting the company. After the capital increase, both parties will enhance cooperation in industrial park development, petrochemical industry investment, and supply chain operations. This capital increase will also help Hebei Xuyang Energy strengthen its capital base and enhance competitiveness.
Related Articles

NAYUKI purchased 847,500 shares for a total of HK$519,000 on June 26.

ZCLOUD TECH CON (09900) announces its annual performance, with a net profit attributable to owners of 6.971 million Hong Kong dollars, a decrease of 77.55% year-on-year.

New Stock News | Fosun Pharma Submits Application to Hong Kong Stock Exchange with Focus on Vaccine Business, No Turnaround in Losses during Reporting Period
NAYUKI purchased 847,500 shares for a total of HK$519,000 on June 26.

ZCLOUD TECH CON (09900) announces its annual performance, with a net profit attributable to owners of 6.971 million Hong Kong dollars, a decrease of 77.55% year-on-year.

New Stock News | Fosun Pharma Submits Application to Hong Kong Stock Exchange with Focus on Vaccine Business, No Turnaround in Losses during Reporting Period

RECOMMEND





